FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
Links shared publicly online about this topic.
- 1,516total visits
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
View full resource at drugs.com
Tags: COPD, COPD Medication, Disease and Condition, FDA, Spiriva, Pulmonology
Most Recently Shared on December 20, 2009 at 8:19 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW /via @drugscom
Also Shared By:
Spiriva HandiHaler approved for the reduction of COPD exacerbations - MPR
empr.com — “Spiriva HandiHaler (tiotropium powder for oral inhalation, from Boehringer Ingelheim and Pfizer) has been approved by the FDA for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on December 21, 2009 at 4:59 pm By:
MPR News: Spiriva HandiHaler approved for the reduction of COPD exacerbations: Spiriva HandiHaler (tiotropium powde... http://bit.ly/6ritCw
Press Releases | Pfizer: the world's largest research-based pharmaceutical company
pfizer.com — “An archive of all Pfizer press releases issued in the United States. Intended as a reference for U.S. investors and journalists.” View full resource at pfizer.com
Most Recently Shared on December 18, 2009 at 2:31 pm By:
FDA approves SPIRIVA® HandiHaler® for the reduction of COPD exacerbations http://bit.ly/5Skobh
Advertisement
Drugs.com
@Drugscom
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
1 year ago...